PEI, BEST, TRCH and IDRA among midday movers
- BySeeking Alpha-
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Idera Pharmaceuticals Inc (IDRA)
NASDAQ
Symbol | Exchange | Currency |
|---|
1.0100
-0.0100(-0.98%)
- Volume:293,173
- Bid/Ask:1.0100/1.0200
- Day's Range:1.0100 - 1.0400
IDRA Overview
- Prev. Close
- 1.02
- Day's Range
- 1.01-1.04
- Revenue
- -
- Open
- 1.02
- 52 wk Range
- 0.977-6.14
- EPS
- -1.79
- Volume
- 293,173
- Market Cap
- 50.53M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 2,523,185
- P/E Ratio
- -
- Beta
- 1.78
- 1-Year Change
- -55.07%
- Shares Outstanding
- 50,033,297
- Next Earnings Date
- Aug 11, 2021
What is your sentiment on Idera Pharmaceuticals Inc?
or
Vote to see community's results!
Idera Pharmaceuticals Inc News
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20%
- ByInvesting.com-
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Technology, Consumer Services and Oil & Gas sectors led shares higher. At the close in NYSE,...
- Idera Pharmaceuticals up 22% following insider share purchase
- BySeeking Alpha-
Idera Pharmaceuticals Inc Analysis
- Idera Completes Recruitment In Late-Stage Melanoma Study
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced that it has completed patient enrollment in the phase III ILLUMINATE-301 study, evaluating tilsotolimod in combination with...
- Axovant's GM1 Gangliosidosis Candidate Gets Orphan Drug Tag
Axovant Gene Therapies Ltd. (NASDAQ:AXGT) announced that the FDA has granted an Orphan Drug designation to its investigational gene therapy candidate, AXO-AAV-GM1, being...
- Idera Pharmaceuticals, Inc. (IDRA) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) . The stock has moved higher by 25% in the past month, while it is...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Strong Sell | Neutral | Strong Sell | Strong Sell |
| Summary | Buy | Strong Sell | Neutral | Strong Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,733.20 | 2,765.00 | 2,706.70 | +95.2 | +3.61% | 3.53M | NASDAQ | |||
| 373.75 | 377.54 | 367.00 | +5.94 | +1.61% | 15.75M | NASDAQ | |||
| 155.40 | 162.91 | 153.55 | -12.20 | -7.28% | 202.31K | NYSE | |||
| 88.64 | 90.00 | 84.67 | -2.68 | -2.93% | 1.74M | NASDAQ | |||
| 195.27 | 196.40 | 189.76 | +9.20 | +4.94% | 27.09M | NYSE | |||
| 53.14 | 53.92 | 52.94 | -0.04 | -0.08% | 18.37M | NASDAQ | |||
| 194.95 | 196.46 | 189.95 | +2.87 | +1.49% | 14.72M | NASDAQ | |||
| 43.49 | 43.74 | 42.26 | +1.39 | +3.30% | 37.29M | NYSE | |||
| 301.29 | 302.39 | 296.98 | +0.81 | +0.27% | 3.73M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 61.27 | 61.55 | 60.43 | +0.11 | +0.18% | 678.09K | NYSE | |||
| 21.15 | 21.25 | 20.91 | +0.16 | +0.76% | 7.23M | NYSE | |||
| 38.91 | 39.55 | 36.08 | +0.90 | +2.37% | 61.10M | NYSE | |||
| 20.39 | 20.65 | 20.16 | +0.04 | +0.17% | 5.37M | NYSE | |||
| 13.13 | 13.25 | 12.91 | +0.18 | +1.39% | 1.72M | NYSE |
Idera Pharmaceuticals Inc Company Profile
Idera Pharmaceuticals Inc Company Profile
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Read More
- 2021-07-27 00:36:37Why this stock is not soaring they decreased their debt to a very low level and they have a huge cashflow
- 2021-06-22 15:16:06$3 very soon 🚀🚀🚀
- 2021-06-25 16:27:38
Why? - 2021-06-28 16:17:42
Because God is investitor
- 2021-04-01 20:29:06yeah guessing this is a going concern issue....massive liabilities and current ratio so if they don't get that under control this is done....is this sort of business model and massive insane debt common in these pharma companies?
- 2021-03-30 14:19:15
will sound very boring but the good old STOP LOSS seems like a good idea here... - 2021-03-23 13:35:40What on earth is going with this......Very odd....and there really still are shorts on this??? crazy.....I guess greed knows no bounds on either side....adding more to my $2 calls...will bounce back hard
- 2021-03-23 09:48:32
Short covered. 4mill short now. - 2021-03-22 21:40:18going to 0Show previous replies (1)
- 2021-03-23 13:41:24Easy and Quick Trans Accounting hertz was down to first 0.50 so this goign near 0. get out
- 2021-03-23 13:42:53Like I said....there will be a short squeeze before this goes down so much.....plus I dont think they will go down they have been in the 1.5-2 range before....this is good time to buy very very cheap calls....ive got time on it
- 2021-03-23 21:45:58Easy and Quick Trans Accounting this is only down... better get out it will go near to 0
- 2021-03-22 17:40:56Wow all other trash and garbaaaage in market but for some strange this continues to go down....crazy
- 2021-03-22 16:01:26Take it cool with this. There is an 10mill shares short on this by 19.03. Outstanding shares 38 mill. Sure they will add to that short.
- 2021-03-22 17:42:05Yep MMs will strike very swift and start the short squeeze......Just how duuuum are you to short an under $2 some short sellers literally have zero brains.....Zero upside for shorties insane downside.....perfect stock for a short squeeze....calls are immensely cheap....adding another 20 $2 calls here
- 2021-03-22 14:03:35Loo more down??? suprising very surprising with so many shorties guess wallstreet ignoring this play for now.....time to add more cheap cheap $2 calls
- 2021-03-22 14:05:58
think it will go down further ?
- 2021-03-19 19:09:27so i cant find it so maybe sameone els can but does idera have any other prodjects its working on that can bring the price up in the next few week / months ?
- 2021-03-21 17:29:44Tons
- 2021-03-19 18:11:24why went down
- 2021-03-19 18:10:00Did they basically shut down trading on this already.....Great buy here....loading up heavy on the $2 April calls.
- 2021-03-19 16:53:37I just read they may go bust. Why are you buying ?Show previous replies (5)
- 2021-03-19 18:11:17Because some people still believe in the buy low sell high mantra...way better buying this for a recovery play then any of the overinflated and overpriced garbage offered in the market that all the sheep is buying this....buying this makes sense buying tech, spy or most of the market doesn't...
- 2021-03-19 19:15:55Rick Geurts https://www.marketwatch.com/story/idera-pharmaceuticals-stock-plunges-after-disappointing-trial-results-prompting-analyst-downgrade-2021-03-19?mod=mw_quote_news
- 2021-03-19 19:43:38Rick Geurts https://seekingalpha.com/news/3674481-idera-pharma-to-face-substantial-financial-risk-after-trial-setback-wedbush?utm_source=investing.com&utm_medium=referral
- 2021-03-19 16:30:51bought 650 usd next week will be great.
- 2021-03-19 16:26:49bought 500 just for the ride
- 2021-03-19 13:38:42gues i be buying 25 of this stock just to be sure i think it will go back to 3,5 ~4 in a week or 3~5 so hope it goes well
- 2021-03-19 12:34:40phase 3 fail...
- 2021-03-19 12:39:26?
- 2021-03-19 12:40:31a ty news has been updated great help
- 2021-03-19 12:31:40so i was looking at this stock anyone know the resoan for the dip Stock Split or just bad day ?
- 2021-03-19 12:28:41intresting a big dip buying some to let i grow will be intesting to see where it goes from 1,9
- 2019-08-09 16:06:28
Bought again- 2019-09-05 15:42:50Sold, I am out of here!
- 2019-08-05 15:36:14I guess I did not learn. I am long again!
- 2019-08-07 15:23:56Sold
- 2019-07-30 15:16:02Sold and I am out of here!
- 2019-07-30 13:49:38trying to sell @ 2.70
- 2019-07-09 19:18:21
bought some more today total 2500 shares
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.